Cargando…
Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010
SUMMARY: The probability of initiating with anti-osteoporosis therapy increased from 7 % in 2000 to 46 % in 2010. This improvement was greater for patients over the age of 75 years. Men, those overweight, having dementia or exposed to antipsychotics, sedatives/hypnotics or opioid analgesics were sig...
Autores principales: | Klop, C., Gibson-Smith, D., Elders, P. J. M., Welsing, P. M. J., Leufkens, H. G. M., Harvey, N. C., Bijlsma, J. W. J., van Staa, T.-P., de Vries, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483189/ https://www.ncbi.nlm.nih.gov/pubmed/25963232 http://dx.doi.org/10.1007/s00198-015-3098-x |
Ejemplares similares
-
Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density
por: Klop, Corinne, et al.
Publicado: (2016) -
Long-term persistence with anti-osteoporosis drugs after fracture
por: Klop, C., et al.
Publicado: (2015) -
The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm
por: Klop, Corinne, et al.
Publicado: (2015) -
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
por: Klop, C., et al.
Publicado: (2013) -
Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands
por: de Vries, F., et al.
Publicado: (2007)